Simplex Trading’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Simplex Trading’s Portfolio PHAS Stock Details PHAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,400	Closed	-$1K	–	11608
2022 Q1	$1K	Sell	1,400 -1,900	-58%	-$3.08K	﹤0.01%	10234
2021 Q4	$8K	Sell	3,300 -7,200	-69%	-$21.8K	﹤0.01%	9264
2021 Q3	$38K	Hold	10,500	–	–	﹤0.01%	7863
2021 Q2	$39K	Buy	10,500 +10,486	+74,900%	+$34.9K	﹤0.01%	7958
2021 Q1	$4K	Buy	14 +11	+367%	+$45	﹤0.01%	8316
2020 Q4	$1K	Buy	+3	New	+$11	﹤0.01%	8196
2020 Q3	–	Sell	-40	Closed	-$18K	–	8790
2020 Q2	$18K	Buy	+40	New	+$177	﹤0.01%	6311

Other funds holding PHAS

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HLA

Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return

IIA

IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Simplex Trading's PHAS Position: Q4 2022 in Review

Simplex Trading sold out of PhaseBio Pharmaceuticals, Inc. Common Stock (PHAS) in Q4 2022, closing a stake of 3,317 shares.

Simplex Trading first reported a position in PHAS in Q2 2020 and held it in 7 quarters. The position peaked at $30K in Q4 2021. 5 funds tracked by Wall St. Rank hold PHAS as of Q4 2022.

Simplex Trading reported no remaining PhaseBio Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Simplex Trading sold 3,317 PhaseBio Pharmaceuticals, Inc. Common Stock shares in Q4 2022.
Simplex Trading first reported a position in PhaseBio Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Simplex Trading's PhaseBio Pharmaceuticals, Inc. Common Stock position peaked at $30K in Q4 2021.
5 funds tracked by Wall St. Rank held PhaseBio Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.